Roberta Di Turi
Roberta Di Turi publishes mostly in Economics and Econometrics, Cardiology and Cardiovascular Medicine and Immunology, on topics such as Health Systems, Economic Evaluations, Quality of Life, Dermatology and Skin Diseases and Biosimilars and Bioanalytical Methods.
- World rank
- #6,600,499 of 7,710,434 ranked researchers
- Rank in Italy
- #215,611 of 242,206
- Works
- 23
- Citations
- 122
- Citations per work
- 5.3
What does Roberta Di Turi research?
Roberta Di Turi's work is mostly in Medicine (27%), Economics, Econometrics and Finance (17%), Immunology and Microbiology (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else1148.3%
- Health Sciences626.7%
- Medicine626.7%
- Social Sciences416.7%
- Life Sciences28.3%
- 1Economics and Econometrics17% of their works
- 2Cardiology and Cardiovascular Medicine10% of their works
- 3Immunology8% of their works
- 4Dermatology7% of their works
- 5Surgery7% of their works
- 6Rheumatology3% of their works
Research topics
- Health Systems, Economic Evaluations, Quality of Life
- Dermatology and Skin Diseases
- Biosimilars and Bioanalytical Methods
- Pharmaceutical Economics and Policy
- Atrial Fibrillation Management and Outcomes
- Blood Pressure and Hypertension Studies
- SARS-CoV-2 and COVID-19 Research
- Pharmaceutical studies and practices
Which keywords describe Roberta Di Turi's research?
The keywords of their largest research topics: Cost-effectiveness Analysis, Quality of Life, Filaggrin, Skin Microbiome, Biosimilars, Drug Development Costs, Generic Drugs and Immunogenicity.
- SARS-CoV-2
- Off-Label Drug Use
- Coronavirus
- Atrial Fibrillation
- Immunogenicity
- Drug Development Costs
- Skin Microbiome
- Quality of Life
- Cost-effectiveness Analysis
- Filaggrin
- Biosimilars
- Generic Drugs
- Anticoagulant Therapy
- Blood Pressure
- Hypertension
- Pediatric Pharmacokinetics
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 16 words, with their numbers
- Cost-effectiveness Analysis61 topic
- Quality of Life61 topic
- Filaggrin41 topic
- Skin Microbiome41 topic
- Biosimilars31 topic
- Drug Development Costs31 topic
- Generic Drugs31 topic
- Immunogenicity31 topic
- Anticoagulant Therapy21 topic
- Atrial Fibrillation21 topic
- Blood Pressure21 topic
- Coronavirus21 topic
- Hypertension21 topic
- Off-Label Drug Use21 topic
- Pediatric Pharmacokinetics21 topic
- SARS-CoV-221 topic
Where does Roberta Di Turi work?
Roberta Di Turi's main affiliation in the publication record is Azienda Sanitaria Locale Roma 3, Italy.
How many publications and citations does Roberta Di Turi have?
OpenAlex counts 23 works and 122 citations for Roberta Di Turi, an h-index of 6, ranking #6,600,499 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Roberta Di Turi. Posts are plain text and can be reported.